Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Thomas Jefferson University at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Thomas Jefferson University brings 17 presentations to ASH 2026 in New Orleans. Its program spans sickle cell disease, platelet function and artificial intelligence in hematology practice. It covers a GRK5 variant that enhances platelet procoagulant activity and antihypertensives in cytokine release syndrome with bispecifics.

OrganizationASH 2026 Attendance
Universities & research institutes
Private university and academic health system in Philadelphia, Pennsylvania.
Symposium
Fri Dec 11
7:00am–10:00am
A Hematologist’s Guide to the Sickle Cell Disease Revolution: Genes, Activators, and Beyond
Approved and emerging gene therapies and new pyruvate kinase activators for sickle cell disease, and how to match patients to each and refer them.
Red cells · Cell & gene

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Thomas Jefferson University

Tell us what you sell and we’ll find the people at Thomas Jefferson University most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction